7/16/23, 11:47 PM CDC - Malaria - Travelers - Malaria Information and Prophylaxis, by Country

Malaria

Malaria

Malaria Information and Prophylaxis, by Country [P]

The information presented in this table is consistent 1 with the information in the CDC Health Information for International
Travel (the “Yellow Book”).

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Key
Information
Needed and
Helpful Links to
Assess Need for
Prophylaxis for
Drug Malaria Recommended Select
Country Areas with Malaria Resistance2 Species3 Chemoprophylaxis4 Countries

Pakistan All areas (including all Chloroquine P. vivax 80%, Atovaquone-proguanil, Altitude of
cities) at altitudes < P. falciparum doxycycline, mefloquine, or city(ies) of travel
2,500 m (8,202 ft) 20% tafenoquine5 Altitude
information 

Palau None Not Not Not Applicable

Applicable Applicable

Panama Present in the Chloroquine P. vivax 97%, Provinces of Darien City(ies) of travel
provinces of Bocas (east of the P. falciparum (including Emberá), Guna Map of Provinces
del Toro, Chiriqui, Panama 3% Yala, and eastern Panama in Panama to
Colon, Darien Canal) province: Atovaquone- determine if a
(including Emberá), proguanil, doxycycline, city is within a
Kuna Yala (also mefloquine, primaquine5, certain province
spelled Guna Yala), or tafenoquine5. Bocas del 
Ngäbe-Buglé, eastern Toro, Chiriqui, Colon,
Panama province, Ngäbe-Buglé, and
and Verugas. None in Veraguas: Atovaquone-
Panama Oeste, the proguanil, chloroquine,
Canal Zone, and doxycycline, mefloquine,
Panama City. primaquine,5 or
tafenoquine.5

Papua Present throughout Chloroquine P. falciparum Atovaquone-proguanil, Altitude of

New country at altitudes < (both P. 75%, doxycycline, mefloquine, or city(ies) of travel
Guinea 2,000 m (6,562 ft) falciparum P. vivax tafenoquine5 Altitude
and P. vivax) 25%;P. information 
malariae and
P. ovale rare

Paraguay None Not Not Not applicable

applicable applicable

https://www.cdc.gov/malaria/travelers/country_table/p.html 1/3
7/16/23, 11:47 PM CDC - Malaria - Travelers - Malaria Information and Prophylaxis, by Country

Key
Information
Needed and
Helpful Links to
Assess Need for
Prophylaxis for
Drug Malaria Recommended Select
Country Areas with Malaria Resistance2 Species3 Chemoprophylaxis4 Countries

Peru All departments < Chloroquine P. vivax 80%, Atovaquone-proguanil, 1) City(ies) of

2,500 m (8,202 ft), P. falciparum doxycycline, mefloquine, or travel
including the cities of 20% tafenoquine5 2) Province(s) of
Iquitos and Puerto travel
Maldonado, and only 3) Altitude of
the remote eastern city(ies) of travel
regions of La Libertad Altitude
and Lambayeque. information and
None in the following to determine if a
areas: Lima Province; city is within a
the cities of Arequipa, certain province.
Ica, Moquegua, 
Nazca, Puno, and Map of provinces
Tacna; the highland of Peru  
tourist areas (Cuzco,
Machu Picchu, and
Lake Titicaca); and
along the Pacific
Coast.

Philippines Present in Palawan Chloroquine P. falciparum Atovaquone-proguanil, 1) City(ies) of

and Mindanao 85%; doxycycline, mefloquine, or travel
Islands. None in P. vivax 15%; tafenoquine5 2) Island(s) of
metropolitan Manila P. travel
and other urban knowlesi,7 P. 3) Altitude of
areas. malariae, city(ies) of travel
and P. ovale Altitude
rare information and
to determine if a
city is within a
certain Island. 
Map of
Administrative
divisions of the
Philippines. 

Pitcairn None Not Not Not Applicable

Islands Applicable Applicable
(U.K.)

Poland None Not Not Not Applicable

Applicable Applicable

Portugal None Not Not Not Applicable

Applicable Applicable

Puerto None Not Not Not Applicable

Rico (U.S.) Applicable Applicable

https://www.cdc.gov/malaria/travelers/country_table/p.html 2/3
7/16/23, 11:47 PM CDC - Malaria - Travelers - Malaria Information and Prophylaxis, by Country

1. Factors that affect local malaria transmission patterns can change rapidly and from year to year, such as local weather conditions, mosquito
vector density, and prevalence of infection. Information in these tables is updated regularly.
2. Refers to P. falciparum malaria unless otherwise noted.
3. Estimates of malaria species are based on best available data from multiple sources. Where proportions are not available, the primary species
and less common species are identified.
4. Several medications are available for chemoprophylaxis. When deciding which drug to use, consider specific itinerary, length of trip, cost of
drug, previous adverse reactions to antimalarials, drug allergies, and current medical history. All travelers should seek medical attention in the
event of fever during or after return from travel to areas with malaria.
5. Primaquine and tafenoquine can cause hemolytic anemia in persons with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Before
prescribing primaquine or tafenoquine, patients must be screened for G6PD deficiency using a quantitative test.
6. Mosquito avoidance includes applying topical mosquito repellant, sleeping under an insecticide treated bed net, and wearing protective
clothing (e.g., long pants and socks, long sleeve shirt). For additional details on mosquito avoidance, see:
https://www.cdc.gov/malaria/travelers/index.html
7. P. knowlesi is a malaria species with a simian host (macaque). Human cases have been reported from most countries in Southeast Asia and are
associated with activities in forest or forest-fringe areas. This species of malaria has no known resistance to antimalarials.
Page last reviewed: November 3, 2021

https://www.cdc.gov/malaria/travelers/country_table/p.html 3/3